RxDoctor Payments DataLook up a doctor →

Phillip Horwitz, MD

Interventional Cardiology · Iowa City, IANPI 1124016787

Payments from drug & device makers

$2,017,524in general payments, 2019–2025

Across 378 payments — averaging $5337.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$917K
  • Edwards Lifesciences$655K
  • W. L. Gore & Associates, Inc.$169K
  • Novartis$149K
  • Medtronic$117K
  • Amgen$8K
  • plus $4K from 11 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,017,524 in reported general payments places this provider in the 95th percentile of 64 interventional cardiology providers in Iowa.

See all interventional cardiology providers in Iowa

Medicare billing

Part B allowed, 2024
$151,481
Medicare patients
561
Services billed
1,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →